Colin Church, MD, discusses durable 6MWD and NT-proBNP signals in a TPIP open-label extension and what phase 3 needs to show next.
Colin Church, MBBS, PhD
Advertisement
Pulmonologist, University of Glasgow
Articles by Colin Church, MBBS, PhD
Colin Church, MD, discusses 24-month open-label extension data showing TPIP remains tolerable in patients with PH-ILD, with no new safety signals.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
eGFR Underestimates CKD in Patients with Cancer, Study Finds
2
42% on Povetacicept Reach KDIGO-Aligned UPCR Target in RAINIER
3
VA Dialysis Tied to Lower Mortality, With Virginia Wang, PhD, MSPH
4
Q&A: Early-Career Dermatology Pearls on Defensive Patients and HS Coding
5